Role of common sarcomeric gene polymorphisms in genetic susceptibility to left ventricular dysfunction
Authors:
- 13 April 2016
- journal article
- research article
- Published by Springer Nature in Journal of Genetics
- Vol. 95 (2) , 263-272
Abstract
Mutations in sarcomeric genes are common genetic cause of cardiomyopathies. An intronic 25-bp deletion in cardiac myosin binding protein C (MYBPC3) at 3 ′ region is associated with dilated and hypertrophic cardiomyopathies in Southeast Asia. However, the frequency of sarcomeric gene polymorphisms and associated clinical presentation have not been established with left ventricular dysfunction (LVD). Therefore, the aim of the present study was to explore the association of MYBPC3 25-bp deletion, titin (TTN) 18 bp I/D , troponin T type 2 (TNNT2) 5 bp I/D and myospryn K2906N polymorphisms with LVD. This study includes 988 consecutive patients with angiographically confirmed coronary artery disease (CAD) and 300 healthy controls. Among the 988 CAD patients, 253 with reduced left ventricle ejection fraction (LVEF ≤ 45%) were categorized as LVD. MYBPC3 25-bp deletion, TTN 18 bp I/D and TNNT2 5 bp I/D polymorphisms were determined by direct polymerase chain reaction method, while myospryn K2906N polymorphism by TaqMan assay. Our results showed that MYBPC3 25-bp deletion polymorphism was significantly associated with elevated risk of LVD (LVEF P< 0.001; and nonLVD versus LVD: OR = 1.65, P = 0.035), while TTN 18 bp I/D , TNNT2 5 bp I/D and myospryn K2906N polymorphisms did not show any significant association with LVD. The results also showed that MYBPC3 25-bp deletion polymorphism was significantly associated with other parameters of LV remodelling, i.e. LV dimensions (LV end diastole dimension, LVEDD: P = 0.037 and LV end systolic dimension, LVESD: P = 0.032). Our data suggests that MYBPC3 25-bp deletion may play significant role in conferring LVD as well as CAD risk in north Indian population.Keywords
Funding Information
- Indian Council of Medical Research (IN) (45/6/2013-HUM-BMS)
- Department of Biotechnology , Ministry of Science and Technology (IN) (BT/PR15017/MED/12/498/2010)
This publication has 37 references indexed in Scilit:
- Cardiac Troponin T ( TNNT2 ) Mutations Are Less Prevalent in Indian Hypertrophic Cardiomyopathy PatientsDNA and Cell Biology, 2012
- Association of 25 bp Deletion in MYBPC3 Gene with Left Ventricle Dysfunction in Coronary Artery Disease PatientsPLOS ONE, 2011
- Myospryn is a calcineurin‐interacting protein that negatively modulates slow‐fiber‐type transformation and skeletal muscle regenerationThe FASEB Journal, 2011
- Limited Distribution of a Cardiomyopathy‐Associated Variant in IndiaAnnals of Human Genetics, 2010
- A common MYBPC3 (cardiac myosin binding protein C) variant associated with cardiomyopathies in South AsiaNature Genetics, 2009
- On the Operational Characteristics of the Benjamini and Hochberg False Discovery Rate ProcedureStatistical Applications in Genetics and Molecular Biology, 2007
- Cardiac myosin binding protein c phosphorylation is cardioprotectiveProceedings of the National Academy of Sciences, 2006
- The role of a common TNNT2 polymorphism in cardiac hypertrophyJournal of Human Genetics, 2004
- Genomic Organisation, Alternative Splicing and Polymorphisms of the Human Cardiac Troponin T GeneJournal of Molecular and Cellular Cardiology, 1998
- Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findingsThe American Journal of Cardiology, 1986